Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

(Home Study) Xarelto for PAD 2023


Fee

$0.00

CE Hours

2.00

CE Units

0.200

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
 WellStar Health System is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

Participants who view the entire activity, complete and pass the post-test (>70%) and complete the activity evaluation will receive CE credit.
Credit will be uploaded electronically and be available in CPE Monitor after completion of required elements.

Support/Credits

No commerical support.

 

 

   

Objectives

  • Describe the pathophysiology and diagnostic criteria of peripheral artery disease (PAD).
  • Discuss the risk factors, clinical presentation, and complications associated with PAD.
  • Differentiate between the stages of disease progression and identify current treatment recommendations for PAD.
  • Evaluate current literature supporting the use of rivaroxaban for the management of PAD.

Speaker(s)/Author(s)

Kosha Patel, PharmD
PGY1 Pharmacy Resident, Wellstar Cobb Hospital

Activity Number

0483-0000-23-016-H01-P

Release Date: Jun 29, 2023
Credit Expiration Date: Jun 29, 2024

CE Hours

1.00

Location

via MS Teams and CH
   

   

Objectives

  • Describe the risk factors, clinical presentation, and complications associated with PAD.
  • Distinguish between the different treatment options available for PAD.

Speaker(s)/Author(s)

Kosha Patel, PharmD
PGY1 Pharmacy Resident, Wellstar Cobb Hospital

Activity Number

0483-0000-23-016-H01-T

Release Date: Jun 29, 2023
Credit Expiration Date: Jun 29, 2024

CE Hours

1.00

Location

via MS Teams and CH